Full Text View
Tabular View
No Study Results Posted
Related Studies
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
This study is currently recruiting participants.
Study NCT00004317   Information provided by Office of Rare Diseases (ORD)
First Received: October 18, 1999   Last Updated: May 13, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Toxoplasmosis
Additional conditions recognized in this trial
Toxoplasmosis, Congenital
More general conditions related to this trial
Central Nervous System Diseases
Central Nervous System Infections
Central Nervous System Parasitic Infections
Central Nervous System Protozoal Infections
Coccidiosis
Infant, Newborn, Diseases
Nervous System Diseases
Parasitic Diseases
Protozoan Infections
Interventions listed in this trial
Leucovorin calcium
Pyrimethamine
Spiramycin
Sulfadiazine
Additional drug interventions recognized in this trial
Leucovorin
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Antimalarials
Antiparasitic Agents
Antiprotozoal Agents
Coccidiostats
Enzyme Inhibitors
Folic Acid Antagonists
Growth Substances
Micronutrients
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Vitamin B Complex
Vitamins
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)
University of Chicago


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services